34

BrainStorm

February 21, 2023

Rudy Tanzi and the Latest Alzheimer’s Drugs - part 1

Rudy Tanzi and the Latest Alzheimer’s Drugs - part 1

About This Episode

Will 2023 be a boom or bust year for new Alzheimer’s drugs? 

In this episode of BrainStorm host Meryl Comer talks with Dr. Rudy Tanzi, Vice-Chair of Neurology at Massachusetts General Hospital, Co-Director of the McCance Center for Brain Health and Professor at Harvard Medical School.  Dr. Tanzi discusses the promising new drugs in a highly charged scientific environment and how these drugs have opened the door to advancement in the treatment of Alzheimer’s. 

Support the show

BrainStorm Feed

105
March 17, 2026 | 26:17

Chipping Away at the Crisis (Part 2): Navigating Alzheimer’s from Diagnosis to Care with Dr. Jason Karlawish

Host Meryl Comer continues her conversation with Dr. Jason Karlawish, professor of medicine, medical ethics, and neurology at the University of Pennsylvania, about the evolving

LISTEN NOW
104
March 3, 2026 | 27:17

Promoted and Caregiving - The Reality Young Professionals Don't Talk About

What happens when your carefully mapped career path collides with an Alzheimer's diagnosis — and you're only 26? In this deeply personal episode of BrainStorm

LISTEN NOW
103
February 17, 2026 | 23:13

Chipping Away at the Crisis - A New Era in Alzheimer's Diagnosis and Treatment with Dr. Jason Karlawish

Alzheimer's disease is no longer just a memory problem — it's a biological, cultural, and ethical challenge reshaping how we think about aging, identity, and

LISTEN NOW